Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

Web

News

Please enter a web search for web results.

News

Web
@Pharmacy_Times
pharmacytimes.com > view > ada-2026-semaglutide-add-on-reduces-glycemic-burden-cardiometabolic-risk-in-older-adults-with-t2d

ADA 2026: Semaglutide Add-On Reduces Glycemic Burden, Cardiometabolic Risk in Older Adults With T2D

2+ mon, 2+ week ago   (365+ words) Adding semaglutide to existing regimens in older adults with inadequately controlled T2D significantly reduced HbA1c, fasting blood glucose, body weight, and blood pressure. Polypharmacy, potentially inappropriate medications, and clinically relevant drug-drug interactions have been associated with lower quality-of-life outcomes in older adults…...